glp-1 drug news today 2025 Weight-loss makers announce pricing agreement with Trump 2025 dominates for GLP-1 trial
Description
GLP-1 drugs like Wegovy or Zepbound have their place, but phentermine remains a practical and empowering tool especially for motivated patients ready to take control of their weight
Therefore, these drugs should not be given to people with uncontrolled T2D, polyuria, and polydipsia or people who develop severe symptoms that predispose to volume depletion (for example vomiting)
Instead, it depends on targeted symptom assessment and risk stratification
McGinley AM, Edwards SC, Raverdeau M, Mills KHG
This role extends beyond dispensing into active risk management
2013;36(5):641649A
